Popliteal Sciatic Nerve Block

A. Onset was faster with the subparaneural injection (about 11 versus 18 minutes) and sensory block lasted longer

Sensory duration was about 397 minutes subparaneural against 265 minutes extraneural, and the success rate rose too. The trial randomised needle-tip position and measured the difference; it did not test why, so the usual account — that the paraneural sheath holds local anaesthetic against the nerve instead of letting it disperse — is an explanation offered for the finding rather than a mechanism this study demonstrated. Note that unintentional intraepineural injection occurred in 8% of patients overall: whatever is gained by working at that depth comes with a narrower margin.

Both techniques succeeded in 92% of patients, and total anaesthesia-related time — performance plus onset — was 17.1 to 19.7 minutes in both. The triple-injection technique had a shorter onset (12.5 versus 15.8 minutes) but needed three needle passes instead of one and a longer needling time. I would teach the single injection: for the same success rate and the same total time to a usable block, it involves a third of the needle passes and a shorter needling time. Be careful how you argue that, though. This trial found procedural discomfort and the incidence of paraesthesia similar between the groups, so fewer passes is an argument from the count of passes and from needling time, not from any harm this study demonstrated. And the reason usually given for expecting one injection to suffice — that once local anaesthetic is under the paraneurium the sheath itself distributes it circumferentially — is the authors' stated hypothesis going in, not something the trial measured.

The endpoint that matters is total anaesthesia-related time, not onset time. A technique that starts working three minutes sooner but takes longer to perform has not saved anyone anything.

Because the trial was too small to exclude a difference that would matter. The authors say so themselves: on the 95% confidence intervals they could not rule out an intergroup difference of up to 19% in success rate and up to 7.83 minutes in total anaesthesia-related time. A 19% difference in success is clinically large, so "no significant difference" here means the trial did not detect one, not that one does not exist. Sonographic neural swelling was also seen in five subjects across the two groups, and two patients had residual numbness at one week which had resolved by one month.

Absence of a significant difference in a 68-patient trial is a statement about the trial's power. Read the width of the confidence interval before you call two techniques equivalent — the authors of this one did exactly that in print.